Bruce Gregory Robinson | |
---|---|
Born | 13 September 1956 |
Nationality | Australian |
Education |
|
Alma mater | University of Sydney |
Known for | Research into endocrine tumours |
Awards | Companion of the Order of Australia |
Medical career | |
Profession | Professor of Medicine |
Field | Endocrinology |
Bruce Gregory Robinson AC (born 13 September 1956 [1] ) is an Australian endocrinologist, medical researcher, and professor of medicine. He served as the Dean of Sydney Medical School within the University of Sydney from 2007 to 2016. His research has focused particularly on endocrine cancers. In 2020, he was awarded the Companion of the Order of Australia for his eminent service to medicine.
Robinson graduated with a Bachelor of Medicine and Bachelor of Surgery (MBBS) from the University of Sydney in 1980, followed by a Master of Science (MSc) from the same university, where his thesis was Vasopressin and the neurohypophysis. [2] He worked at the Royal Alexandra Hospital for Children and Royal North Shore Hospital before undertaking a fellowship at Harvard Medical School between 1986 and 1989. During this fellowship, he conducted molecular research work at the Brigham and Women’s Hospital and Boston Children’s Hospital (Harvard Medical School affiliates), culminating in 1991 with the award of a Doctor of Medicine (MD), where his thesis was Studies Of Corticotropin And Arginine Vasopressingene Expression. [3] [4] [5] [6] [7]
Robinson is a Fellow of the Royal Australasian College of Physicians (FRACP). [8] He was the head of the Division of Medicine at the Royal North Shore Hospital in Sydney from 1998 to 2006, and he continues to practise as an endocrinologist there. Following that, Robinson served as the dean of Sydney Medical School from 2007 to 2016. [9] Until 2016, he also served as the associate dean (International) at the Faculty of Medicine in the University of Sydney. [4] [10] [6]
In 1989, after gaining his doctorate, Robinson established the Molecular Genetics Unit, now known as the Cancer Genetics Unit, at the Kolling Institute of Medical Research in the Royal North Shore Hospital. He described this as "one of the most challenging phases of his career". [7]
His research has primarily focused on identifying the genetic factors that contribute to tumour formation in endocrine glands, including the thyroid, parathyroid, adrenal, and pituitary glands. His research posts include: [10]
His service to medical organizations includes: [10]
In the 2020 Australia Day Honours, Robinson was awarded Australia's highest civilian honour, Companion of the Order of Australia, "for eminent service to medical research, and to national healthcare, through policy development and reform, and to tertiary education". [17]
Other recognition includes: [10]
As of March 2025 [update] , Scopus lists 377 publications by Robinson, which have been cited 27,107 times, and an h-index of 81. [21]
He has also written or contributed to books with a focus on thyroid disorders and endocrine neoplasia, including: